|
|
|
Company Name
|
Gilead Sciences Inc.
|
|
Drug Name
|
Truvada (sNDA)
|
|
Event Name
|
FDA decision on Truvada in new indication as HIV preventive therapy
|
|
Event Date
|
09/14/2012
|
|
Outcome
|
FDA approved Truvada as HIV preventive therapy on Jul.16
|
|
Drug Status
|
|
|
Rival Drugs
|
|
|
Market Potential
|
|
|
Other Approvals
|
|
|
News |
|
|
|
Return to FDA Calendar
|